Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119610 · ClinicalTrials.gov registry record · Phase 1
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
A Phase 1 study of Obesity and Aging, sponsored by Sara Espinoza.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT03119610 is a Phase 1 study of Obesity and Aging that has completed, run by Sara Espinoza. The registered enrollment target is 23 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03119610, a Phase 1 study of Obesity and Aging, has completed, sponsored by Sara Espinoza.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Obesity is highly prevalent in older adults and is a major cause of sarcopenia and disability in older adults. Although exercise can counteract the effects of obesity and sarcopenia, many have difficulty adhering to an exercise program and the benefits of exercise are variable. Therefore, there is an urgent need to test novel pharmacologic interventions to prevent disability and loss of independence. Oxytocin is a pituitary hormone released during parturition and lactation that is also known to suppress appetite in rodents and humans; and, recent small studies have found that intranasal oxytocin reduces body weight in adults. We propose a pilot study of intranasal oxytocin as a novel approach to promote weight loss and increase muscle mass in older subjects with sarcopenic obesity.
Conditions Studied
Interventions
- DRUG Oxytocin nasal spray
- DRUG Placebo nasal spray
Study Locations (1)
Texas
- Texas Diabetic Institute - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2019-12-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03119610
The ClinicalTrials.gov registry entry for NCT03119610 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The listed sponsor is Sara Espinoza, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin nasal spray is the first listed.
NCT03119610 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03119610 about?
NCT03119610 is a clinical study titled "The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity". Obesity is highly prevalent in older adults and is a major cause of sarcopenia and disability in older adults. Although exercise can counteract the effects of obesity and sarcopenia, many have difficulty adhering to an exercise program and the benefits of exercise are variable. Therefore, there is a...
What is the current status of trial NCT03119610?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2017-09-22. Estimated completion is 2019-12-17.
What conditions does trial NCT03119610 study?
This clinical trial studies the following conditions: Obesity, Aging, Sarcopenia, Sedentary Lifestyle, Sarcopenic Obesity.
What interventions are being tested in trial NCT03119610?
The interventions under investigation include: Oxytocin nasal spray (DRUG), Placebo nasal spray (DRUG).
Who is sponsoring clinical trial NCT03119610?
This trial is sponsored by Sara Espinoza, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03119610 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
RECRUITING · Phase 1
-
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
RECRUITING · Phase 1
-
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
RECRUITING · Phase 1
-
A Study of LY3971297 in Healthy Participants
RECRUITING · Phase 1
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.